Peptide questions · Cagrilintide
How long does cagrilintide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Cagrilintide’s onset is days–2 weeks, its peak effect comes at 26–68 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).
The timeline’s basis: Phase 2 dose-finding RCT (Lau 2021), the cagrilintide-only arm of phase 3 REDEFINE 1 (Garvey 2025) and phase 1b PK (Enebo 2021); the trial escalation is from the phase 2 CagriSema protocol (NCT04982575). Not approved on its own.
Cagrilintide week by week
The library places five of its research notes on cagrilintide on the days they cover, from day 1 to day 364 and on: 5 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | The 0.25 mg start | Randomized trial |
| Days 29–364 (weeks 5–52) | 0.5 mg, the second step | Randomized trial |
| Days 57–364 (weeks 9–52) | 1 mg, the middle step | Randomized trial |
| Days 85–364 (weeks 13–52) | 1.7 mg, the step before 2.4 mg | Randomized trial |
| From day 113 on | 2.4 mg, the phase 3 dose | Randomized trial |

Model. Individual results vary.
The cagrilintide timeline’s milestones
The library’s timeline for cagrilintide marks 6 points from week 1 to week 68, backed by moderate evidence overall.
- Week 1: Commonly reported: fullness arriving a little sooner in meals
- Week 4: Trial step from 0.25 to 0.5 mg, after 4 weeks on the start dose
- Week 8: Commonly reported: smaller portions and less grazing between meals
- Week 16: The trials reach 2.4 mg here, after four 4-week steps
- Week 26: Where its phase 2 trial measured weight change
- Week 68: Where REDEFINE 1 measured its cagrilintide-only arm
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why cagrilintide takes that long
Cagrilintide’s half-life is about 7 days (168 hours), so one dose is about 96.9% cleared after 35 days.
On its schedule (Weekly) the doses overlap, and the level of cagrilintide keeps climbing for about 28–35 days before it levels off, so the first 28–35 days run below the level the later weeks hold.
The notes on cagrilintide follow the trials’ dose steps, 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Cagrilintide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, cagrilintide among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does cagrilintide take to work?
Cagrilintide’s onset is days–2 weeks, its peak effect comes at 26–68 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).
When does cagrilintide reach its peak effect?
By the library’s timeline, cagrilintide’s peak effect comes at 26–68 weeks (trial endpoints), backed by moderate evidence.
How long is cagrilintide usually run?
The library’s timeline gives cagrilintide’s typical duration as ongoing; its cycle note says: Trials run it continuously: 26 weeks in phase 2, 68 weeks in phase 3.
What does the library say about the first days on cagrilintide?
Its first note on cagrilintide, for days 1–28 (weeks 1–4), is “The 0.25 mg start”, resting on randomized trials.